Search Results - Mark A. Galan MD

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Disease Control Achieved Using Atezolizumab + Bevacizumab in a Patient With Sarcomatoid Hepatocellular Carcinoma (SHCC), a Rare Variant Excluded From the IMbrave150 Trial by Maria G. Fencer MD, Catherine H. Davis MD, MPH, Jieqi Liu MD, Mark A. Galan MD, Kristen R. Spencer DO, MPH

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: